KC-764 is an orally active, reversible inhibitor of cyclooxygenase, preferentially targeting platelet cyclooxygenase. It effectively reduces platelet thromboxane A2 (TXA2) production and inhibits platelet aggregation, exhibiting IC50 values of 0.23 μM and 26 nM, respectively. This compound is valuable for research focused on antiplatelet therapy and the prevention of recurrence in ischemic stroke.
KC-764 is an orally active, reversible inhibitor of cyclooxygenase, preferentially targeting platelet cyclooxygenase. It effectively reduces platelet thromboxane A2 (TXA2) production and inhibits platelet aggregation, exhibiting IC50 values of 0.23 μM and 26 nM, respectively. This compound is valuable for research focused on antiplatelet therapy and the prevention of recurrence in ischemic stroke.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
